#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Hormone-dependent prostate cancer Acquired haemophilia Desmoplastic small round cell tumour Keratosis follicular Myeloproliferative neoplasm Lymphangioma Medulloblastoma Cardiac sarcoidosis Hypocalcaemia Anaemia Adult T-cell lymphoma/leukaemia refractory Malignant oligodendroglioma Autoimmune demyelinating disease Angelman's syndrome More trials…

    Learn about Rare Diseases

    Pulmonary sarcoidosis – Life with Disease Lennox-Gastaut syndrome – Treatment Splenic marginal zone lymphoma – Diagnostics Alport’s syndrome Paraneoplastic neurological syndrome – Diagnostics Rhabdomyosarcoma – Life with Disease Chronic granulomatous disease – Trials in Disease Systemic mastocytosis – Life with Disease Leiomyosarcoma metastatic – Basic Information Testicular leiomyosarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Prednisolone Acetate Sodium Butyrate Chloride Ion Lorlatinib Hydroxypropyl Cellulose Lf Vatiquinone Sodium Fluoride (18F) Romidepsin Sorafenib Tosilate Fenoterol Hydrobromide Rituximab Paroxetine Hydrochloride Gelatin Alx148 Nirogacestat Hydrobromide Elebsiran Pegenzileukin Sodium Chloride Solution 0.9% Verapamil Catequentinib Dihydrochloride More therapies…

    Learn about Your Condition

    Venous thrombosis Fracture infection Paraesthesia Myasthenia gravis Hodgkin's disease Measles Breast cancer metastatic Atrial fibrillation Penile cancer Paraganglion neoplasm Deep vein thrombosis Pneumonia bacterial Neuropathic arthropathy Toxic epidermal necrolysis Haemophilia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Dexamethasone for Patients with Advanced Relapsed or Refractory Multiple Myeloma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Dexamethasone
    France

  • Study on the Safety and Effects of ION440 for Patients with MECP2 Duplication Syndrome

    Recruiting

    2 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome
    Investigated Drugs:
    • Ion440
    Austria France Spain

  • Comparing Lidocaine-Prilocaine Cream and Lidocaine Injection for First-Degree Perineal Tear Repair in Women

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Perineal injury
    Investigated Drugs:
    • Prilocaine
    • Lidocaine
    • Lidocaine Hydrochloride
    Spain

  • Study on the Safety and Tolerability of SNDX-5613 for Patients with Relapsed or Refractory Acute Leukemias

    Recruiting

    2 1 1
    Investigated Drugs:
    • N-Ethyl-2-[4-[7-[[4-(Ethylsulfonylamino)Cyclohexyl]Methyl]-2,7-Diazaspiro[3.5]Nonan-2-Yl]Pyrimidin-5-Yl]Oxy-5-Fluoro-N-Propan-2-Ylbenzamide
    • Revumenib
    France Germany Italy Lithuania The Netherlands Spain

  • Study on Long-Term Safety of AAVAnc80-hOTOF Gene Therapy for Patients with Sensorineural Hearing Loss Due to Otoferlin Gene Mutations

    Recruiting

    4 1 1
    Investigated Diseases:
    • Deafness
    Investigated Drugs:
    • Aavanc80-3’Hotof
    • Aavanc80-5’Hotof
    Spain

  • Study of IMP1734, Paclitaxel, and Abiraterone for Patients with Advanced Solid Tumors

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Eik1003
    • Abiraterone
    • Carboplatin
    Denmark France Spain
Previous Page
1 … 320 321 322 323 324 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!